Browsing by Author "Lu, Shun"
Now showing items 1-2 of 2
-
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial
Goss, Glenwood D.; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Felip Font, Enriqueta; Cobo, Manuel (Elsevier, 2021-07) -
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non–small-cell lung cancer
Forde, Patrick; Spicer, Jonathan; Lu, Shun; provencio, mariano; Mitsudomi, Tetsuya; Awad, Mark; FELIP, ENRIQUETA (Future Medicine, 2023-03)